「研究結(jié)果顯示了使用 Robocath 的 R-One 機(jī)器人進(jìn)行機(jī)器人冠狀動(dòng)脈血管成形術(shù)的前景良好」。據(jù)一項(xiàng)針對(duì) 62 名患者的歐洲研究表明，使用 Robocath 的 R-One 機(jī)器人進(jìn)行冠狀動(dòng)脈血管成形術(shù)是安全有效的，并且可以減少醫(yī)生的輻射暴露。 R-One 機(jī)器人專為進(jìn)行冠狀動(dòng)脈血管成形術(shù)（支架植入）而設(shè)計(jì)。從屏蔽輻射的控制站，醫(yī)生使用操縱桿遠(yuǎn)程控制手術(shù)所需的設(shè)備，例如導(dǎo)線，氣球和支架。 R-One 于 2019 年獲得 CE 標(biāo)志，目前在歐洲、非洲和中國(guó)使用。

Study results show promise for robotic coronary angioplasties using Robocath's R-One robot.A European study of 62 patients showed that coronary angioplasties using the R-One robot from Robocath are safe and effective, and reduce physicians' exposure to radiation.The R-One robot is specifically designed to perform coronary angioplasties (stent implantation). From a control station shielded against radiation, the physician uses joysticks to remotely control the devices needed for the procedure, such as guidewires, balloons, and stents. R-One was CE-marked in 2019, and is currently used in Europe, Africa, and China.

Based on these results, the use fo the robot genuinely heralds a new age in the treatment of heart conditions, something that has been sorely needed for 30 years given the significant challenges involved in this discipline, particularly the exposure to X-rays.